NASS is regularly updating their website with relevant COVID-19 information including how patients can assess their risk, medicines and biologic therapy, mental health and the effect of the virus on work and benefits.
www.nass.co.uk/covid19
Aspiring to Excellence programme 2020 open for applications
Following a successful start for the first cohort, applications are now open for the Aspiring to Excellence programme in 2020. The programme is designed to encourage and recognise service improvement in axial SpA (AS) care and is a strategic partnership between NASS, BRITSpA and sponsoring companies AbbVie, Biogen, Novartis and UCB.
Whilst COVID19 is impacting on us all, NASS is keen to keep driving forward as much as is possible and practical with Aspiring to Excellence, and applications are welcome. The deadline for rheumatology teams to apply is 24 July 2020 and all the application details can be found on the NASS website. For further information please contact annamcgilvray@nass.co.